Abstract:BACKGROUND: Alterations in plasma and intestinal metabolites contribute to the pathogenesis and progression of alcohol-related liver cirrhosis (ALC).AIM: To explore the common and different metabolites in the plasma and feces of patients with ALC and evaluate their clinical implications.METHODS: According to the inclusion and exclusion criteria, 27 patients with ALC and 24 healthy controls (HCs) were selected, and plasma and feces samples were collected. Liver function, blood routine, and other indicators were detected with automatic biochemical and blood routine analyzers. Liquid chromatography-mass spectrometry was used to detect the plasma and feces metabolites of the two groups and the metabolomics of plasma and feces. Also, the correlation between metabolites and clinical features was analyzed.RESULTS: More than 300 common metabolites were identified in the plasma and feces of patients with ALC. Pathway analysis showed that these metabolites are enriched in bile acid and amino acid metabolic pathways. Compared to HCs, patients with ALC had a higher level of glycocholic acid (GCA) and taurocholic acid (TCA) in plasma and a lower level of deoxycholic acid (DCA) in the feces, while L-threonine, L-phenylalanine, and L-tyrosine increased simultaneously in plasma and feces. GCA, TCA, L-methionine, L-phenylalanine, and L-tyrosine in plasma were positively correlated with total bilirubin (TBil), prothrombin time (PT), and maddrey discriminant function score (MDF) and negatively correlated with cholinesterase (CHE) and albumin (ALB). The DCA in feces was negatively correlated with TBil, MDF, and PT and positively correlated with CHE and ALB. Moreover, we established a P/S BA ratio of plasma primary bile acid (GCA and TCA) to fecal secondary bile acid (DCA), which was relevant to TBil, PT, and MDF score.CONCLUSION: The enrichment of GCA, TCA, L-phenylalanine, L-tyrosine, and L-methionine in the plasma of patients with ALC and the reduction of DCA in feces were related to the severity of ALC. These metabolites may be used as indicators to evaluate the progression of alcohol-related liver cirrhosis.

Blood serum amino acid pool violation of in patients with liver cirrhosis

Association of ABO blood types with VWF, FⅧ and ADAMTS13 levels and disease severity in liver cirrhosis patients

Serum amino acids changes in liver failure patients treated with non-bio-artificial liver support system

Plasma levels of ascorbic acid and vitamin E in patients with liver cirrhosis

Correlation between plasma amino acid profiles and the various stages of hepatitis B infection

Protein tolerance to standard and high protein meals in patients with liver cirrhosis

Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis.

Tryptophan Metabolites in the Progression of Liver Diseases

Dynamic Elevation of Aromatic Amino Acids in Hepatitis C Virus-Induced Cirrhosis After a Standard Meal

The Clinical Significance of the Change of Blood-Lipid in Patients with Hepatitis B-related Cirrhosis.

Changes in Serum Ammonia Concentration in Cirrhotic Patients with Helicobacter Pylori Infection

Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity

Differences In Serum Amino Acid Phenotypes Among Patients With Diabetic Nephropathy, Hypertensive Nephropathy, And Chronic Nephritis

A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.

[Deviations in the level of serum lipids and higher fatty acids in liver cirrhosis and chronic hepatitis]

Difference and clinical value of metabolites in plasma and feces of patients with alcohol-related liver cirrhosis

Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.

Evaluation of enterohepatic circulation of the bile acids in patients with non-alcoholic fatty liver disease

Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection

Influence Factors of Serum Fibrosis Markers in Liver Fibrosis

Serum Prolactin as a Marker of the Severity of Liver Cirrhosis in a Tertiary Hospital in India: A Cross-Sectional Study